| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |